Snowflake Earnings: Solid Results, But Outlook Disappoints AI-Worried Investors
Snowflake reported 30% product revenue growth & strong bookings in Q4 FY2026, yet in-line Q1 guidance sparked 3% after-hours drop amid AI disruption fears in software.
Snowflake reported 30% product revenue growth & strong bookings in Q4 FY2026, yet in-line Q1 guidance sparked 3% after-hours drop amid AI disruption fears in software.
IonQ crushes Q4 2025 earnings with $61.9M revenue beat, massive growth, strong 2026 guidance, and major moves like SkyWater acquisition—stock rises in after-hours as quantum tech gains momentum.
NVIDIA reports record $68.1B Q4 revenue (+73% YoY) and guides $78B for Q1 2027, beating estimates as AI demand surges. Data center hits $62.3B.
Salesforce smashed Q4 records with Agentforce AI exploding to $800M, yet its FY27 sales forecast of ~$46B disappointed Wall Street. Shares dropped 5% as fears grow that AI startups will steal business.
FDA approves DESMODA, the first ready-to-use liquid medicine for central diabetes insipidus. It helps stop extreme thirst & frequent peeing with easier, safer precise dosing for kids & adults.
The US Department of Commerce is hosting a key roundtable with American robot makers on March 10, 2026, to tackle supply chain issues and policies amid growing competition from China in robotics and humanoids.